The nurse is evaluating outcomes after administering desmopressin ...

[karlynnae]

The nurse is evaluating outcomes after administering desmopressin therapy. Which assessment finding is considered a desired outcome in an adult male client?
 
  1. Urine output of 3,500 mL/day
  2. Urine specific gravity of 1.015
  3. Edema of lower extremities absent
  4. Serum sodium 156 mEq/L

Question 2

The nurse is assessing a client who is newly prescribed to receive supplemental growth hormone therapy. Which parameters should the nurse assess?
 
  1. Bowel sounds, vitamin B12 level, and history of gallbladder disease
  2. Height and weight, head circumference, and EKG
  3. Blood sugar, blood pressure, height, and weight
  4. Urine specific gravity, serum osmolality, and serum electrolytes

[bd5255]

Answer to Question 1

Correct Answer: 2
Rationale 1: A urine output of 3,500 mL/day is high for an adult. Normal output is around 2,500 mL/day.
Rationale 2: Desmopressin is administered to treat diabetes insipidus (DI). The client with DI is typically dehydrated before treatment. A urine specific gravity of 1.015 is normal, which indicates that the treatment has stopped the diuresis associated with DI.
Rationale 3: Lower extremity edema is not typical of DI.
Rationale 4: A serum sodium of 156 mEq/L is too high and indicates that dehydration is still present.
Global Rationale: Desmopressin is administered to treat diabetes insipidus (DI). The DI client is typically dehydrated before treatment. A urine specific gravity of 1.015 is normal, which indicates that the treatment has stopped the diuresis associated with DI. A urine output of 3,500 mL/day is high for an adult. Normal output is around 2,500 mL/day. Lower extremity edema is not typical of DI. A serum sodium of 156 mEq/L is too high and indicates that dehydration is still present.

Answer to Question 2

Correct Answer: 3
Rationale 1: Bowel sounds, the gallbladder, and absorption of B12 are not negatively affected by GH.
Rationale 2: When preparing to administer growth hormone, the nurse should assess height and weight, but the EKG is not affected by GH therapy.
Rationale 3: When preparing to administer growth hormone, the nurse should assess growth to date, including height and weight. Blood sugar and blood pressure can increase as a result of therapy, so baseline values are needed.
Rationale 4: Urine specific gravity, serum osmolality, and serum electrolyte values are not affected by GH.
Global Rationale: When preparing to administer growth hormone, the nurse should assess growth to date, including height and weight. Blood sugar and blood pressure changes can increase as a result of therapy, so baseline values are needed. The other findings are important, but are not directly affected by the administration of GH.

[karlynnae]

Thanks

[bd5255]

Welcome